Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project

被引:86
作者
Coebergh, J. W. W. [1 ]
Reedijk, A. M. J.
de Vries, E.
Martos, C.
Jakab, Z.
Steliarova-Foucher, E.
Kamps, W. A.
机构
[1] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands
[2] Ctr Comprehens Canc, Eindhoven Canc Registry, Eindhoven, Netherlands
[3] Dutch Childhood Oncol Grp, The Hague, Netherlands
[4] Ctr Comprehens Canc, Rotterdam Canc Registry, Rotterdam, Netherlands
[5] Govt Aragon, Canc Registry Zaragoza, Dept Publ Hlth, Zaragoza, Spain
[6] Semmelweis Univ, Hungarian Childhood Canc Registry, Budapest, Hungary
[7] Int Agcy Res Canc, Descript Epidemiol Grp, F-69372 Lyon, France
[8] Univ Groningen, Med Ctr, Paediat Clin, Beatrix Children Hosp, Groningen, Netherlands
关键词
adolescent and childhood; leukaemia; Europe; epidemiology; incidence; survival; registry; trends;
D O I
10.1016/j.ejca.2006.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Leukaemias constitute approximately one-third of cancers in children (age 0-14 years) and 10% in adolescents (age 15-19 years). Geographical patterns (1988-1997) and time trends (1978-1997) of incidence and survival from leukaemias in children (n = 29,239) and adolescents (n = 1929) were derived from the ACCIS database, including data from 62 cancer registries in 19 countries across Europe. The overall incidence rate of leukaemia in children was 44 per million person-years during 1988-1997. Lymphoid leukaemia (LL) accounted for 81%, acute non-lymphocytic leukaemia (ANLL) for 15%, chronic myeloid leukaemia (CML) for 1.5% and unspecified leukaemia for 1.3% of cases. Adjusted for sex and age, incidence of childhood LL was significantly lower in the East and higher in the North than in the British isles. The overall incidence among adolescents was 22.6 per million person-years. The incidence of LL was rising in children (0.6% per year) and adolescents (1.9% per year). During 1988-1997 5-year survival of children with leukaemias was 73% (95% CI 72-74) and approximately 44% for infants and adolescents. Similar differences in survival between children and adolescents were observed for LL, much less so for ANLL. Survival differed between regions; prognosis was better in the North and West than the East. Remarkable improvements in survival occurred in most of the subgroups of patients defined by diagnostic subgroup, age, sex and geographic categories during the period 1978-1997. For children with ANLL most improvements in survival were observed in the 1990s. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2019 / 2036
页数:18
相关论文
共 49 条
[11]   Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study [J].
Gatta, G ;
Luksch, R ;
Coleman, MP ;
Corazziari, I .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (06) :695-702
[12]   Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study [J].
Gilham, C ;
Peto, J ;
Simpson, J ;
Roman, E ;
Eden, TOB ;
Greaves, MF ;
Alexander, FE .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503) :1294-1297
[13]   Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000) [J].
Goubin, A ;
Auclerc, MF ;
Auvrignon, A ;
Patte, C ;
Bergeron, C ;
Hémon, D ;
Clavel, J .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) :534-541
[14]   Infection, immune responses and the aetiology of childhood leukaemia [J].
Greaves, M .
NATURE REVIEWS CANCER, 2006, 6 (03) :193-203
[15]   A pooled analysis of magnetic fields, wire codes, and childhood leukemia [J].
Greenland, S ;
Sheppard, AR ;
Kaune, WT ;
Poole, C ;
Kelsh, MA .
EPIDEMIOLOGY, 2000, 11 (06) :624-634
[16]   Improving outcome through two decades in childhood ALL in the Nordic countries:: the impact of high-dose methotrexate in the reduction of CNS irradiation [J].
Gustafsson, G ;
Schmiegelow, K ;
Forestier, E ;
Clausen, N ;
Glomstein, A ;
Jonmundsson, G ;
Mellander, L ;
Mäkipernaa, A ;
Nygaard, R ;
Saarinen-Pihkala, UM .
LEUKEMIA, 2000, 14 (12) :2267-2275
[17]   Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland [J].
Hjalgrim, LL ;
Rostgaard, K ;
Hjalgrim, H ;
Westergaard, T ;
Thomassen, H ;
Forestier, E ;
Gustafsson, G ;
Kristinsson, J ;
Melbye, M ;
Schmiegelow, K .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (20) :1549-1556
[18]   Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia [J].
Hjalgrim, LL ;
Madsen, HO ;
Melbye, M ;
Jorgensen, P ;
Christiansen, M ;
Andersen, MT ;
Pallisgaard, N ;
Hokland, P ;
Clausen, N ;
Ryder, LP ;
Schmiegelow, K ;
Hjalgrim, H .
BRITISH JOURNAL OF CANCER, 2002, 87 (09) :994-999
[19]   Acute lymphoblastic leukemia incidence during socioeconomic transition:: selective increase in children from 1 to 4 years [J].
Hrusák, O ;
Trka, J ;
Zuna, J ;
Poloucková, A ;
Kalina, T ;
Stary, J .
LEUKEMIA, 2002, 16 (04) :720-725
[20]  
Jaffe E.S., 2001, PATHOLOGY GENETICS T, V3